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Infirmary, Leicester, UKAbdominal aortic aneurysm (AAA) rupture is the 13th commonest cause of death in the Western World. Although
considerable research has been applied to the aetiology and mechanism of aneurysm expansion, little is known about the
mechanism of rupture. Aneurysm rupture was historically considered to be a simple physical process that occurred when the
aortic wall could no longer contain the haemodynamic stress of the circulation. However, AAAs do not conform to the law of
Laplace and there is growing evidence that aneurysm rupture involves a complex series of biological changes in the aortic
wall. This paper reviews the available data on patient variables associated with aneurysm rupture and presents the evidence
implicating biological factors in AAA rupture.Keywords: Abdominal aortic aneurysm; Rupture; Matrix metalloproteinase; Enzyme; Collagen.Introduction
Abdominal aortic aneurysms (AAA) primarily affect
elderly males with a prevalence of 5%. The natural
history of aneurysms is to expand and eventually
rupture. AAA rupture is responsible for 1.5% of the
total mortality in males over 55 years of age, amount-
ing to 8000 deaths per year in England.1 Recent
elucidation of the biological processes causing aneur-
ysm development and expansion has led to transla-
tional research investigating the use of novel
medication aimed at retarding aneurysm growth.
The most promising drugs have been those with either
anti-inflammatory or anti-matrix metalloproteinase
(MMP) properties, both of which have had some
success in experimental models.2–5 However, any
medication strategy for the treatment of AAA must
address aneurysm rupture as well as expansion. In
contrast to the expansion of AAA, the biologicalng author. Prof. M.M. Thompson, MD, FRCS, Depart-
cular Surgery, 4th Floor St James Wing, St George’s
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received little attention.
Abdominal aneurysms were traditionally con-
sidered to be a simple biomechanical problem, result-
ing from irreversible structural damage to the aortic
wall. These changes were thought to result in dilata-
tion and eventual rupture when wall stress from the
circulation exceeded the tensile strength of the aortic
wall. Focusing on aortic wall stress led to a simplistic
view that aneurysm rupture was determined solely by
mechanical factors. Just as the complexity of the
atherosclerotic plaque has become apparent, it is
now recognised that AAA rupture is a multifaceted
biological process involving biochemical, cellular, and
proteolytic influences in addition to biomechanical
factors. The purpose of this review is to provide a
summary of patient variables associated with AAA
rupture and present the evidence implicating biologi-
cal factors in AAA rupture. A MEDLINE search from
1966 until 2004 (OVID and Embase) was performed
using the subject heading ‘abdominal aortic aneur-
ysm’ and keywords ‘rupture’, ‘matrix metalloprotei-
nase’, ‘thrombus’ and ‘stress’. An extensive manualEur J Vasc Endovasc Surg 30, 227–244 (2005)
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relevant key published papers.Patient Variables Implicated in Aneurysm RuptureDiameter
The principal determinant of AAA rupture is the
maximum diameter of the aneurysm. Early investi-
gations that attempted to stratify rupture rates
according to aneurysm diameter were subjected to
many problems. Initial studies relied on autopsy6,7
which did not reflect diameter in vivo.8 Studies in
patients faced the problems of poor reproducibility of
aneurysm diameter measurement by different scan-
ning modalities9 and low rates of autopsy following
sudden deaths in population studies. It is therefore not
unexpected that reported rupture rates varied widely,
from 1% per annum10–12 to as high as 6%13 per annum
for aneurysms!5.0 cm in diameter and from 0.8%14 to
9.4%15 for aneurysms 5.5–5.9 cm. The natural history
data for larger aneurysms were even more difficult to
obtain because most large AAA were surgically
repaired. Contemporary data on the rupture risk of
larger aneurysms have been derived from the non-
surgical arm of the US aneurysm detection and
management (ADAM) Veteran Affairs Cooperative
Study.15 This study prospectively evaluated patients
with AAA larger than 5.5 cm for whom elective repair
was not planned because of medical contraindications
or patient refusal. Estimated annual rupture rates
according to size (pooled data) are summarised in
Table 1.Table 1. Annual rupture rates of abdominal aortic aneurysms
according to size (based on pooled available data)
Initial aneurysm diameter (cm) Annual risk of rupture
3.0 0.2–0.4%165
4.0 0.8–1.1%165
4.0–5.5 0.626–1.012
5.5–5.9 9.4%15*
6.0–6.9 10.2%15
O7.0 30.5166–32.5%15
* The 9.4% 1-year probable rupture rate observed for initial AAA
of 5.5 to 5.9 cm is 10-fold higher than the rates observed in 2
randomised trials12,26 for AAA of 4.0 to 5.5 cm. Lederle et al.15
postulated that whilst this large difference was likely due to the
difference in AAA diameters, it may also reflect a difference in
rupture rates between their mostly high-operative-risk patients (for
whom elective repair was not planned because of medical contra-
indications) and the healthier patients randomised into the trials.
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There is evidence that rapid AAA expansion is
associated with increased rupture risk. Limet et al.16
reported that the risk of aortic rupture was not only
related to aneurysm size but also to the rate of
expansion. These findings were confirmed by Lederle
et al.15 who found a significantly greater mean AAA
enlargement rate in patients with probable rupture
than patients without rupture (0.75 vs. 0.41 cm per
year) and Brown et al.14 who reported increased mean
and median expansion rates in patients with ruptured
AAA than patients without rupture (mean 0.84 vs.
0.39 cm per year). The view that expansion rates are
associated with rupture risk is not universally
accepted. Cronenwett17 argued that it is difficult to
separate the influence of expansion rate on rupture
risk from the effect of expansion rate on absolute
diameter, which itself affects rupture risk. Nevit et al.8
found that the absolute size and not expansion rate
was associated with increased rupture rate, an
observation which was also supported by Cronenwett
et al.13 To determine whether expansion rate per se is
an independent predictor of rupture would require a
large series of patients with similar sized aneurysms
but different expansion rates to be followed without
intervention. Furthermore, individual growth rates are
difficult to predict and AAAs have intervals of
stability, slow and rapid expansion.18 Investigations
on expansion rates should have a minimum 3monthly
follow up to monitor expansion rates accurately19 but
this is expensive, time consuming and highly depen-
dent on patient compliance.
Cronenwett et al.20 found that expansion rate was
dependent on current AAA diameter, rather than a
fixed rate, so that 3–6 cm diameter aneurysms
expanded by 10% of their diameter per year. That
expansion rate is an exponential function of initial
aneurysm diameter has also been supported by other
studies.16,21–23 Limet et al.16 also reported more
rapid growths in larger diameter aneurysms
(5.3 mm/year for AAA diameters less than 40 mm
versus 7.4 mm/year for AAA diameters of 50 mm
or more). Other variables that have been shown to
have a positive correlation with expansion rate are
pulse pressure,20 systolic and diastolic blood
pressures24 and smoking.25 Interestingly, the US
ADAM26 study reported that diabetes was associ-
ated with slower enlargement of aneurysms. This
was consistent with previous observations that
diabetes was associated with a reduced prevalence
of aneurysm,27,28 but the basis for this link remains
unknown.
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The UK Small Aneurysm Trial (UKSAT),29 with a total
of 1090 patients with AAA between 4.0 and 5.5 cm in
diameter randomised to either surgery or serial
ultrasonographic surveillance, reported that the risk
of rupture was independently and significantly associ-
ated with female sex and higher mean blood pressure.
When the analysis included a further 1167 patients
who were ineligible for randomisation, current smok-
ing and lower FEV1 were also found to be associated
with risk of rupture. In contrast, age, body mass index,
serum cholesterol concentration, and ankle/brachial
pressure index were not found to be associated with an
increased risk of aneurysm rupture.
Female sex
When combined with their 1167 non-randomised
patients, the UKSAT reported a three-fold higher risk
of rupture in women compared to men.29 Further-
more, the UKSAT found that the mean diameter
preceding rupture was smaller in women (5.0G
0.8 cm) than in men (6.0G1.4 cm). A smaller study14
found the risk of rupture in women with AAA 5.0–
5.9 cm to be four times that of men with AAA 5.0–
5.9 cm. The US ADAM study26 had very few women
(only 34 total, with four having AAA of 4.0 cm or
greater) and therefore limited conclusions could be
drawn from this study regarding the risk of rupture in
women.
The findings that females with AAA have a higher
rupture risk suggest that when considering the
indications for aneurysm repair, different thresholds
might apply to women than men. In centres with low
operative mortality rate, Brown et al.14 recommended a
threshold of no higher than 5.0 cm in women.
Unfortunately, this threshold has not been tested in
any randomised trial. Protocols from the UKSAT12 and
US ADAM26 studies managed both male and female
patients with an identical threshold for surgery.
Furthermore, since the prevalence of AAA is much
lower in women than men,11 recruitment of large
numbers of women into trials remains a challenging
issue.
Blood pressure
UKSAT29 reported that aneurysm rupture was associ-
ated with higher mean blood pressure. The UKSAT
investigators speculated that weakening of aneurys-
mal wall by the haemodynamic burden of higher
mean blood pressure was a possible reason for this
link. In addition to evidence from the UKSAT,29 the
association between hypertension and AAA rupture
has also previously been demonstrated in earlierstudies.13,30–32 Cronenwett17 reported that diastolic
blood pressure was a more accurate predictor of
aneurysm rupture than systolic blood pressure. In a
review of 75 patients with AAAs, Foster et al.30
observed that 72% of patients with diastolic hyperten-
sion died from aneurysm rupture compared with 30%
of the entire group. In an autopsy study, Sterpetti et
al.31 compared 77 patients who died from AAA
rupture to 220 patients who died with an intact
aneurysm and found that patients with ruptured
AAA more frequently had hypertension (54 versus
28%). In a group of 156 patients, Szilagyi et al.32
reported that hypertension (O150/100 mmHg) was
present in 67% of patients with aneurysm rupture, but
in only 23% of those without rupture.
Chronic obstructive pulmonary disease
Data from the UKSAT29 showed an association
between lower FEV1 and AAA rupture. However,
this association was only apparent after including in
the analysis a further 1167 patients who were ineligible
for randomisation. These patients mainly included
those whose AAA diameter never exceeded 4.0 cm or
who were considered unfit or refused surgery. The
UKSAT investigators acknowledged that inclusion of
these patients could have biased the results. Never-
theless, the association between COPD and AAA
rupture has also been supported by earlier studies.
Sterpetti et al.31 found that patients with ruptured
AAAs more frequently had emphysema (67 vs. 42%)
and Cronenwett et al.13 found that COPD was
independently predictive of AAA rupture and attrib-
uted this to a possible increase in systemic proteinase
activity. However, this hypothesis has never been
proven in experimental studies and current evidence
remains circumstantial. Van Laarhoven et al.33
reported that 19% of COPD patients with severe
emphysema (FEV/vital capacity ratio !55%) had
dilated aortas (O2.5 cm) comparedwith 8% of patients
with less severe COPD, suggesting that patients with
more severe COPD have a greater likelihood of
developing AAA.
Smoking
In addition to smoking being a risk factor for AAA
development34 and expansion,25 it has also been
shown to be a risk factor for AAA rupture. Earlier
studies on the relationship between smoking and
AAA rupture yielded contrasting results. In a large
population based study, Strachan reported the relative
risk of death from AAA rupture to be increased 4.6
fold for cigarette smokers and 2.4 fold for pipe/cigar
smokers.35 On the contrary, Cronenwett et al.13 and
Sterpetti et al.31 did not find that smoking history orEur J Vasc Endovasc Surg Vol 30, September 2005
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rupture. Cronenwett17 raised the issue that COPD
was not specifically measured in the study by
Strachan,35 therefore it was not be possible to separate
the potentially confounding influence of COPD. The
UKSAT29 did measure COPD specifically and reported
that risk of rupture was independently and signifi-
cantly associated with current cigarette smoking. In
the separate analysis of the more homogeneous group
of 1090 randomised patients, the UKSAT29 investi-
gators reported a similar association between smoking
and AAA rupture when baseline plasma cotinine (a
long lived metabolite of nicotine) was used as an index
of smoking.Biomechanical Factors in Aneurysm Rupture
The biomechanical approach to predicting AAA
rupture views stress (internal forces per unit area) on
the aneurysmal wall as the one direct factor leading to
the aortic wall giving way. The basic premise of
biomechanical principles is that AAA formation and
enlargement are accompanied by an increase in wall
stress and/or a decrease in the ability of the material of
the wall to withstand these stresses (i.e. a decrease in
tensile strength). To account for the well established
relationship between AAA size and risk of rupture,
investigators conventionally referred to the biophysi-
cal principle expressed by the law of Laplace,36 where
wall stress is directly proportional to aortic diameter
and blood pressure.
sZ
P!r
t
where s, circumferential wall stress; P, intraluminal
pressure; r, vessel radius; t, thickness of wall vessel.
However, it is now known that stress distributions
in aneurysms do not conform to the approximations of
the law of Laplace. The law of Laplace yields only an
estimate of the average stresses generated in thin wall
cylinders. This equation is derived from assumptions
that render it incompatible with the complex geo-
metrical structure of an aneurysm. Mower et al.37
claimed that the method of finite element analysis
(FEA), a recognized discipline in engineering sciences,
predicted stress distributions in hypothetical aneur-
ysm models with greater accuracy. FEA involved
dividing a large complex structure into a finite number
of smaller individual elements with their own geo-
metric shape and material properties. Engineering
analysis techniques were then used to determine the
behaviour of these individual elements. By studying
the effects of transmission of forces of each individualEur J Vasc Endovasc Surg Vol 30, September 2005element to other elements, the behaviour of a complex
structure could be determined.
FEA analysis of an axisymmetric and fusiformAAA
model by Elger et al.38 found that maximum stress was
a function of the shape of the AAAwall rather than its
diameter. While FEA analyses incorporated the effect
of AAA shape in the determination of wall stress, this
is not considered in the law of Laplace. The finding
that wall stress was greatly dependent on the shape as
well as the size of the aneurysm was confirmed by
Vorp et al.39 In their study, the peak wall stress for a
hypothetical model of non-aneurysmal aorta was
approximately 9 N/cm2, whereas that for a 4-cm
AAA and an 8-cm AAA was approximately 23 and
45 N/cm2, respectively. Using a hypothetical model of
a small aneurysm, FEA calculations by Mower et al.37
were opposite to that predicted by the law of Laplace
in that stress was greatest on the inner surface of the
wall and decreased nonlinearly as the outer wall was
approached.
However, these earlier studies were limited by the
assumptions of idealized geometry and simplified
mathematical models for aneurysmal tissue. Ragha-
van et al.40 extended these earlier studies by using FEA
to estimate AAA wall stress distribution from simul-
taneously determined 3D computer tomography (CT)
reconstruction of abdominal aortic wall geometry and
blood pressure. This study reported that in all AAA
cases, the wall stress was complexly distributed, with
large regional variations of high and low stress. Peak
wall stress among AAA patients varied from 29 to
45 N/cm2. Assuming that wall strength does not vary
regionally within the AAA, the site of maximum stress
would also likely be the site most susceptible to
rupture. Peak wall stress was localised to the posterior
surface in all cases studied, consistent with the
observation by Darling et al.41 that the majority of
ruptures occurred on the posterior surface. In contrast,
the wall stress on the non-aneurysmal aorta in the
control subject was relatively low and uniformly
distributed, with a peak wall stress of 12 N/cm2.
Statistical analysis of the computed geometric factors
suggested that AAA volume, rather than AAA
diameter, was the best indicator of peak wall stress
and, consequently, AAA rupture.
Using 3D CT reconstruction and in vivo FEA
analysis of peak wall stress, Fillinger et al.42 and
more recently, Venkatasubramaniam et al.43 found that
ruptured or symptomatic AAAs had a significantly
higher peak wall stress compared to asymptomatic
AAAs, independent of blood pressure or AAA
diameter. In addition, these in vivo measurements of
peak wall stress using FEA predicted rupture risk
more accurately than law of Laplace. The smallest
Abdominal Aortic Aneurysm Rupture 231ruptured AAA was 4.8 cm, but this aneurysm had a
stress equivalent to the average electively repaired 6.3-
cm AAA. In a later study by Fillinger et al., FEA of
peak wall stress was applied to 103 patients under
observation.44 This study showed that patients who
later required emergent repair had higher peak wall
stress during observation.Limitations of Biomechanical Approach
Despite encouraging results, studies on FEA have
limitations. Fillinger et al.42 acknowledged that in
some of the symptomatic patients, the only available
blood pressure was at the time of symptoms and it was
therefore uncertain whether the acute symptoms
caused hypertension or whether hypertension caused
high aneurysm wall stress that led to acute pain.
Selection bias was also possible because patients who
were not stable enough for a CT scan were excluded.
Furthermore, these studies assume a uniform aortic
wall thickness and ignored the effect of thrombus on
wall stress. Some investigators have reported that
intraluminal thrombus lowered the stress in the
aneurysm wall37,45–47 whilst others have reported
intraluminal thrombus to increase AAA expansion/
rupture risk.48,49
Although these studies took into account the
complex geometrical shape of AAAs, the investi-
gations did not address differences in wall tensile
properties. By measuring tensile properties in aneur-
ysmal and control tissues, Vallabhaneni et al.50
reported that material properties of the aneurysm
wall were markedly heterogeneous both within and
between patients. These findings showed that finite
element methods, by incorrectly assuming aneurysm
wall to be homogeneous, might therefore be highly
inaccurate. Secondly, these investigators also demon-
strated clear differences in the tensile properties of
non-aneurysmal aorta in the longitudinal and trans-
verse directions and suggested that such anisotropy
exists in aneurysms. If so, this highlights a further
inadequacy in finite element methods that assumes
aneurysm to be isotropic. The marked heterogeneity
and high intersubject variation of aneurysm wall
strength suggested that there are focal areas of
weakened aortic wall.Paradigm Shift in Concepts of AAA Rupture
The observation that the risk of aneurysm rupture is
primarily determined by aortic diameter seems to
support the concept that aortic rupture occurs whenthe wall stress exceeds the tensile strength of the
altered aortic wall. However, the relationship between
aortic rupture and wall stress is more complex than
first envisaged. There are few data to support the
assumption that excessive stress acting upon the aortic
wall is the only cause of rupture. It has been well
documented that aneurysms can rupture at virtually
any size.13,51 The traditional biomechanical notions of
AAA rupture therefore appear insufficient to explain
the clinical behaviour of all AAAs. Consideration must
also be given to the fact that small AAAs are those in
the earliest stage of evolution, when the capacity for
connective tissue repair maybe high. Large AAAs,
however, are also the most longstanding and will have
a decreased capacity for connective tissue repair.52 The
concept of a localised process of ageing with the
exhaustion of the repair potential of cells in larger
AAAs seems to be supported by studies which found a
pattern of accelerated replicative senescence of smooth
muscle cells (SMCs) derived from AAA tissue.53
Recent advances in our understanding of the role of
enzymes in the pathobiological processes within AAA
have led to a paradigm shift in our concepts of AAA
rupture. Based on the findings of tensile strength
heterogeneity within aneurysms, Vallabhaneni et al.50
proposed that ‘hot spots’ of increased biologic activity
(enzyme activation) within aneurysmal wall may be
responsible for focal weakening and aneurysm rup-
ture at relatively low levels of intraluminal pressure.50
The notion that AAA rupture may be related to
increased enzymatic activity in the aortic wall was first
proposed following anecdotal observations that surgi-
cal procedures precipitated AAA rupture. In a retro-
spective study, Swanson et al.54 described 10 patients
with known asymptomatic aneurysms that ruptured
within an average of 10 days after laparotomy for
another condition and suggested that the laparotomy
may have precipitated rupture of the unresected
abdominal aneurysms by raising levels of endo-
geneous collagenase. Nora et al.,55 in their series of
17 patients with coexistent AAA and colon carcinoma,
found a 14% incidence of AAA rupture in patients
who underwent colon resection only. Trueblood et al.56
reported an 11% incidence of AAA rupture that
occurred within 3 days of operation for intraabdom-
inal malignancy. The hypothesis that collagenase may
be activated at sites distant from an initial injury was
supported by an experimental study by Hawley et al.57
that found increased collagenase activity within the
small bowel, caecum, and stomach after colon resec-
tion in rabbits. However, other investigators have
questioned these clinical and laboratory findings.
Durham et al.58 found a low incidence (3%) of post-
operative AAA rupture in patients who underwent aEur J Vasc Endovasc Surg Vol 30, September 2005
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postoperative AAA rupture was reported by Hertzer
et al.59 and Acinapura et al.60 Cohen et al.61 showed that
laparotomy, bowel resection, and even aortic mobiliz-
ation had no effect on aortic collagenase activity in
rats. However, these findings must be interpreted
cautiously because collagenase behaviour in humans
and rats may differ.Role of Enzymes in the Pathophysiology of AAA
It is widely accepted that an AAA is the end result of a
multifactorial process culminating in irreversible
pathological remodelling of the aortic wall connective
tissue62 (Fig. 1). The most prevalent features of
endstage AAA segments are: degradation of the
viscoelastic protein elastin, compensatory increased
collagen synthesis and content, excessive inflamma-
tory infiltration consisting of T-cells, B-cells and
macrophages, apoptosis of vascular smooth muscle
cells (VSMCs) and excessive medial neovascularisa-
tion. The overall result is gradual imbalance between
the synthesis and degradation of elastin and collagen
leading to permanent diffuse alteration of the matrix
structure of the vessel wall in aneurysms.63–66
Although the exact mechanisms are unknown, there
is compelling evidence to indicate that the pathophy-
siology of AAAs is associated with increased proteo-
lytic capacity within the abdominal wall, which is
primarily attributed to elevated concentration and
activity of matrix metalloproteinases (MMPs). MMPs
are a family of endopeptidases with proteolytic
activity towards the important structural elements in
the aortic wall—elastin and interstitial collagen.67 Four
MMPs, including 72-kD gelatinase (MMP-2), 92-kD
gelatinase (MMP-9), matrilysin (MMP-7), and macro-
phage elastase (MMP-12), are predominantly elas-
tases, whereas at least three other MMPs (MMP-1, -8
and -13) are enzymes specific for interstititial col-
lagens.68 Based on substrate specificity the MMPs are
categorized into 6 groups (Table 2). Other enzymes
that may participate in connective tissue degeneration
are plasmin, plasminogen activators,69 their inhibi-
tors,70,71 serine elastases and cathepsins.72 In different
laboratories and with various experimental
approaches, MMPs have consistently materialised as
key participants in aneurysm disease. The role of
MMPs in the pathophysiology of AAAs has been
comprehensively reviewed elsewhere68,73,74 and will
therefore be limited in this review to a table summary
(Table 3) of a series of published experimental studies
on MMPs and AAAs.Eur J Vasc Endovasc Surg Vol 30, September 2005Role of Enzymes in AAA RuptureProtein content of the aortic wall
Ex vivo mechanical testing of healthy and aneurysmal
abdominal aortic wall specimens75,76 revealed that the
failure strength of a typical AAAwall was lower than
that of non-aneurysmal aorta. It seems likely that the
increased local production of enzymes capable of
degrading elastin and interstitial collagen67 alters the
structural integrity and predisposes the aortic wall to
weakening.65 During the formation of AAAs, the
elastin concentration decreases whilst the collagen
concentration increases.63 Sumner et al.77 demon-
strated the relative depletion of elastin in aneurysmal
tissue, a finding that was confirmed by subsequent
studies.51,78 This phenomenon reflected the increased
elastin disruption by elastases and insufficient elastin
production by senescent VSMCs. In contrast, the
collagen concentration of aneurysmal aorta was
found to be elevated in several studies.63,79,80 McGee
et al.81 showed that mRNA levels for f 1-procollagen
were increased in AAA tissue extracts and suggested
that the increase in collagen concentration in aneur-
ysmal tissue was due to increased collagen synthesis
and deposition. This was thought to be due to a
compensatory response to increase in wall stretch,82 a
phenomenon which has been observed in vitro.83
Others claimed that the increase in collagen concen-
tration was a dilutional effect caused by selective
degradation of elastin in the aneurysmal media.79
It is generally accepted that the distensible elastic
fibres of the aortic media are responsible for load-
bearing at physiologic pressures whereas adventitial
collagen acquires load-bearing function at higher
pressures84 In the normal aorta, collagen and elastin
are arranged in such a way that confers resistance to
stretch, with the main load being placed upon the
elastin fibres.85 The degradation of elastin in aneur-
ysmal tissue is thought to initiate arterial dilatation.
Elastic fibres are distributed to a larger area as the
collagen concentration and aortic diameter increase.63,
80 All these changes result in the gradual increase of
both aortic diameter63 and haemodynamic stress, and
the transfer of tensile stress in the aortic wall to
collagen fibres.65,86,87 The collagen content increases as
the aneurysm increases in size.80,88 This network
contains predominantly type I and III collagen,89,90
with collagen type III responsible for most of its tensile
characteristics.79
However, these compensatory processes have an
endpoint. Beyond this threshold, the collagen net-
work cannot maintain the biophysical properties of
Fig. 1. Chain of biological events leading to abdominal aortic aneurysm rupture.
Abdominal Aortic Aneurysm Rupture 233the aneurysm65,66,91 and the aneurysm becomes at
high risk of rupture. Once an AAA becomes
established and prior to rupture, it is primarily
composed of types I and III collagen. Naturally,
AAA resistance to rupture must be dependentupon the tensile strength provided by these
collagen networks.92 It therefore seems likely that
the final common pathway of clinical progression
of AAAs to rupture involves proteolytic degra-
dation of aortic collagen fibres.Eur J Vasc Endovasc Surg Vol 30, September 2005
Table 2. The major MMP subtypes and their substrates
MMP Enzyme Principal substrates
Collagenases
MMP-1 Collagenase-1 (Interstitial collagenase) Collagens I, II, III, VII, VIII, X, gelatin, aggrecan, MMPs-2 and -9
MMP-8 Collagenase-2 (Neutrophil collagenase) Collagens I, II, III, V, VII, VIII, X, gelatin, aggrecan
MMP-13 Collagenase-3 Collagens I, II, III, IV, gelatin, aggrecan, PAI2
MMP-18 Collagenase-4 (Xenopus collagenase) Collagen I
Gelatinases
MMP-2 Gelatinase A (72 kDa gelatinase) Gelatin, collagens I, IV, V, VII, X, XI, XIV, elastin, fibronectin,
aggrecan
MMP-9 Gelatinase B (92 kDa gelatinase) Gelatin, collagens IV, V, VII, X, elastin
Stromelysins
MMP-3 Stromelysin-1 Collagens III, IV, IX, X, gelatin, aggrecan, MMPs-1, -7, -8, -9, -13
MMP-10 Stromelysin-2 Collagens III, IV, V, gelatin, casein, MMPs-1 and -8
MMP-11 Stromelysin-3 Gelatin, collagen IV, fibronectin, casein, proteoglycans
Matrilysins
MMP-7 Matrilysin-1 (PUMP-1) Collagens IV, X, fibronectin, gelatin
MMP-26 Matrilysin-2 Collagen IV, fibronectin, gelatin, proMMP-9, fibrinogen
Membrane type MMPs
MMP-14 MT1-MMP Collagens I, II, III, gelatins, MMPs-2 and -13
MMP-15 MT2-MMP MMP-2, gelatin
MMP-16 MT3-MMP MMP-2
MMP-17 MT4-MMP Gelatin, proMMP-2
MMP-24 MT5-MMP Proteoglycans, proMMP2, collagen I, gelatin, fibronectin, laminin
MMP-25 MT6-MMP Collagen IV, proMMP-8, proMMP-9
Others
MMP-12 Macrophage metalloelastase Collagen IV, gelatin, elastin, fibronectin
E. Choke et al.234Experimental studies
Dobrin et al.93 investigated the proteolytic effects of
purified collagenase and elastase on arterial tissue. At
supraphysiological pressures, collagen and elastin
were degraded differentially in isolated canine com-
mon carotid arteries and human external, internal and
common iliac arteries. Treatment with collagenase
caused the blood vessels to dilate, become more
compliant and rupture. In contrast, treatment with
elastase caused the vessels to dilate markedly and
become stiffer (probably due to recruitment of pre-
viously unstretched collagen fibres) but was not
related to rupture. These findings have fostered the
notion that elastin degradation is a key step in the
development of aneurysmal dilatation but collagen
degradation is ultimately required for aneurysm
rupture. It must be recognised when interpreting
these studies that there is some collagenase activity
in elastase and some of the results could therefore be
related to changes in collagen. The investigators stated
that they used the most purified elastase and
collagenase available, and that the results were
reproducible; every vessel treatedwith elastase dilated
but never ruptured, whereas every vessel treated with
collagenase dilated only slightly but did rupture.
Animal studies provided evidence for the role of
tissue inhibitor of matrix metalloproteinases (TIMP)-1Eur J Vasc Endovasc Surg Vol 30, September 2005in preventing medial degradation and aneurysm
formation by inhibiting the MMPs involved in the
disruption of the media. Silence et al.94 showed that
aneurysms in thoracic and abdominal aortas were
more frequent in mice with combined deficiency of
apoE and TIMP-I genes compared with single
deficiency of ApoE genes. In their experiments,
MMP activity was most pronounced at sites where
degradation of the elastic lamina occurred. Lemaitre et
al.95 showed that mice with combined deficiency of
apoE and TIMP-I genes, fed on a cholesterol-rich diet,
developed aortic medial ruptures and formed pseu-
doaneurysms. In these mice, the elastic lamellae were
degraded and infiltrated with macrophages. The
gelatinolytic activity associated with the macrophages
was abolished by the addition of TIMP-1.
Allaire et al.96 demonstrated that local inhibition of
MMP activity by TIMP-1 had the potential to inhibit
aneurysm rupture. This group seeded vessels with rat
SMCs, transfected with a retroviral vector containing
TIMP-1 cDNA. This had the effect of preventing
aneurysmal degeneration and rupture. This group
argued that it was very likely that TIMP-1 inhibited
destruction of the wall by blocking MMPs since the
elastic layers were preserved and the activity of MMP-
9, activated MMP-2 and 28 kD caseinase and elastase
were all decreased. In a similar experiment, the same
group demonstrated that blockade of plasminogen
Table 3. Summary of published series reporting the role of enzymes in the pathophysiology of AAA
Enzymes Summary of findings Author Year
MMP-9 Increased levels MMP-9 in explant AAA than AOD or normal aorta. MMP-9 localised
to macrophages
Thompson et al.167 1995
MMP-9 expression localised to macrophages McMillan et al.128 1995
Increased expression MMP-9 mRNA in AAA Tamarina et al.168 1997
Increased expression and activity of MMP-9 in AAA Elmore et al.169 1998
Freestone et al.98 1995
Saito et al.170 2002
Tung et al.171 2001
Yamashita et al.172 2001
Significant proportion of MMP-9 found to be active in AAAwall Sakalihasan et al.173 1996
Monocytes cultured with aortic explants infiltrated tissue, produced MMP-9 and
degraded elastic fibres
Katsuda et al.174 1994
Targeted gene disruption of MMP-9 prevented aneurysmal degeneration in mice Pyo et al.175 2000
No significant difference inMMP-9 mRNA and protein between AAA and AOD tissue* Davis et al.176 1998
MMP-2 Increased MMP-2 protein and mRNA in AAA compared to AOD tissues Davis et al.176 1998
McMillan et al.129 1995
Increased MMP-2 activation and binding to tissue matrix in AAA compared to AOD
aorta
Davis et al.176 1998
Increased levels MMP-2 in vasculature (inferior mesenteric veins) remote from the
aorta in patients with AAA
Goodall et al.177 2001
MMP-2 complemented and facilitated the degenerative activity of MMP-9 in
transgenic murine models
Longo et al.178 2002
Increased amounts of MMP-2 protein and mRNA production by cultured aortic SMCs
compared to SMCs from AOD tissues
Crowther et al.179 2000
No significant difference between MMP-2 mRNA level between AAA and control
(AOD and organ donor aorta)*
Elmore et al.169 1998
No significant difference in MMP-2 staining by immunohistochemistry between AAA
and AOD tissue*
Knox et al.180 1997
MMP-12 Increased MMP-12 in AAA compared to normal aorta and localisation of MMP-12 to
residual elastin especially areas adjacent to nondilated normal aorta
Curci et al.181 1998
Deficiency of MMP-12 in mice conferred protection against medial destruction and
ectasia
Luttun et al.182 2004
Targeted gene disruption of MMP-12 did not suppress elastase-induced aneurysmal
degeneration*
Pyo et al.175 2000
MT1-MMP Increased MT1-MMP protein and mRNA in AAA compared with normal and AOD
tissue
Nollendorfs et al.183 2001
MT1-MMP localised to the media in the same distribution as MMP-2 giving indirect
evidence for its role in MMP-2 regulation
Crowther et al.184 2000
Immunodepletion of MT1-MMP blocked a significant portion of the proteolytic
activation of pro-MMP2
Rajavashisth et al.185 1999
Collagenase -1
(MMP-1)
Increased pro MMP-1, MMP-1 protein and mRNA levels in AAA compared to healthy
aorta
Irizarry et al.186 1993
Annabi et al.187 2002
Tamarina et al.168 1997
MMP-1 localised within mesenchymal cells (SMCs and fibroblasts) Newman et al.130 1994
Capillary endothelial cells synthesised MMP-1 in response to cytokine stimulation Rifkin et al.188 1990
No significant difference in MMP-1 mRNA in AAA compared to AOD tissue* Mao et al.158 1999
Variable expression of MMP-1 in AAA and difficulty in demonstrating excess
collagenase activity in soluble tissue extracts*
Evans et al.189 1991
Herron et al.190 1991
Menashi et al.79 1987
Bussutil et al.191 1980
Webster et al.192 1991
Collagenase -2
(MMP-8)
Inconsistent expression of MMP-8 in AOD and AAA tissue. However, MMP-8 is stored
as preformed protein in granules154,155 and therefore MMP-8 mRNA may not
accurately reflect protein concentration
Mao et al.158 1999
Collagenase -3
(MMP-13)
Increased expression of MMP-13 in AAA compared to AOD tissue and localisation of
MMP-13 to SMCs in close spatial proximity to collagen
Mao et al.158 1999
Tissue inhibitors
of MMPs (TIMPs)
Increased ratio between enzyme (MMP-2 and -9) and inhibitor (TIMP-1 and -2) mRNA
in AAA
Tamarina et al.168 1997
Increased ratio between MMP-2 and its inhibitor TIMP-2 and between MMP-1 and -3
and their inhibitor TIMP-1 in AAA
Knox et al.180 1997
More frequent abdominal aneurysms in mice with combined deficiency of apoE and
TIMP-1 compared with single deficiency of apoE
Silence et al.94 2002
Gelatinolytic activity associated with macrophages in mice aorta abolished by the
addition of TIMP-1
Lemaitre et al.95 2003
* Contrary evidence.
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E. Choke et al.236activators also inhibited MMP activity and prevented
formation of aneurysms and arterial rupture.70 Guinea
pig-to-rat aortic xenografts seeded with syngeneic rat
SMCs, retrovirally transduced with the rat plasmino-
gen activator inhibitor-1 (PAI-1) gene, did not rupture
or become aneurysmal whereas all grafts not seeded
with cells ruptured within 14 days. Overexpression of
PAI-1 was related to decreased levels of tissue
plasminogen activator (t-PA), 28-kD caseinase, and
activated MMP-9, and preservation of elastin.Clinical evidence
The pathological processes associated with the natural
history of aneurysms to dilate and rupture are not well
documented in clinical studies. The relationship
between aortic diameter and MMP activity and
expression has been examined in several studies.98,84
Data from these investigations provided circumstan-
tial evidence that MMP-2 promoted propagation of
smaller AAA, but MMP-9 activity was associated with
larger aneurysms. Freestone et al.98 used zymography
and immunassay to show increased concentrations of
MMP-2 in small aneurysms (4–5.5 cm in diameter),
and increased activity of MMP-9 in larger aneurysms
(O5.5 cm). It was therefore postulated that increased
expression and activation of MMP-2 played a role in
early aneurysmal dilatation by degrading elastin,
whereas MMP-9, by its association with larger
aneurysms, predisposed the aneurysm to rapid
growth and rupture. McMillan et al.84 used polymer-
ase chain reaction (PCR) methodology to show that
moderate-diameter AAAs (5–7 cm) had significantly
higher MMP-9 mRNA expression than either small
(!5 cm) or large (O7 cm) AAAs. These authors
speculated that the increased MMP-9 expression was
related to the continued expansion of moderate sized
aneurysms but the lower levels of MMP-9 expression
in aneurysms O7 cm suggested that the rapid expan-
sion and higher rupture rates that characterise very
large aneurysms were probably related to other
factors.
Anderton et al.99 showed that serum MMP-1 levels
were increased 2.5 fold and serum MMP-9 levels were
increased 6 fold in ruptured compared to non-
ruptured AAA. Petersen et al. investigated the activity
of MMP-2 and -9 in 20 medium sized (diameter 5!
7 cm) AAAs, 20 large sized (O7 cm) AAAs and 20
ruptured AAAs using semi-quantitative substrate gel
zymography. Their results showed a significantly
higher MMP-9 activity in ruptured AAA compared
to large non-ruptured AAA but no difference in MMP-
2 activity. These investigators concluded that highEur J Vasc Endovasc Surg Vol 30, September 2005MMP-9 activity was associated with AAA rupture.
However, this study was limited in the selection of
patients and the methodology employed to define
MMP activity or concentrations.
Anderton et al.100 used enzyme linked immunosor-
bent assay (ELISA) to quantify levels of MMP-1, -2, -3,
-9 and -13 and TIMPs-1 and -2 and found no
significant differences in these levels in the AAA sac
of large (O6.5 cm) and medium (5–6.5 cm) sized
aneurysms, or ruptured and non-ruptured AAA sac.
When the same group analysed paired samples of
aortic sac obtained from the anterior sac and the site of
rupture in nine patients with ruptured AAA, MMP-9
was seven times higher at the site of rupture than in
the anterior sac, suggesting that localised elevations in
MMP-9 may have a role in focal aortic wall weakening
and AAA rupture. This concept of localised ‘hot spots’
of MMP hyperactivity was supported by Vallabhaneni
et al.50 This group demonstratedmarked heterogeneity
of tensile strength and MMP activity in aneurysmal
walls but failed to correlate MMP-2 and -9 activities to
the physical properties of the wall. The absence of this
correlation could be due to the fact that these
investigators were unable to measure the MMP
activity and physical properties in the same specimen.
Instead, MMP assay was conducted from an area close
to the specimen subjected to tensile strength testing.Role of Inflammation and Immune Response in
AAA Rupture
A prominent histologic feature of end stage AAAs is
extensive inflammatory infiltration consisting of T-
cells, B-cells and macrophages. The cause of the
inflammatory process is unknown, and possibilities
include autoimmune reaction101,102 or an infectious
agent such as Chlamydia pneumoniae.103 Soluble pep-
tide fragments derived from the degradation of
extracellular matrix components, including elastin,
laminin and fibronectin, may serve as a chemotactic
agent for infiltrating macrophages through inter-
actions with the 67-kD cell surface elastin-binding
protein found on inflammatory cells.104 The trigger for
the recruitment of leukocytes is not yet known, but
may include the local production of chemotactic
cytokines (chemokines) such as interleukin-8 (IL-8),
monocyte chemoattractant protein-1 (MCP-1) and
RANTES (regulated on activation normal T-cell
expressed and secreted).105 Their elevated levels in
human and experimental AAA tissues105,106 coupled
with their potent chemotactic properties suggest that
they are likely to play a role in the influx andmigration
Abdominal Aortic Aneurysm Rupture 237of inflammatory cells, especially T-lymphocytes and
monocytes.
Anidjar et al.107 used elastase-induced model of
AAA in rats to demonstrate that inflammation
correlated with aneurysm formation. It is likely that
inflammatory cells release a cascade of pro-inflamma-
tory cytokines that results in the activation of
proteolytic enzymes.108 Human and experimental
AAA tissues have been shown to produce abundant
amounts of prostaglandin E2 (PGE2), tumour necrosis
factor-a (TNF-a), interleukin-1b (IL-1b) and interleu-
kin-6 (IL-6).109–113 These cytokines may play a major
role in tissue injury by inducing the expression and
activation of MMPs and TIMPs.105
Although chronic inflammation is a dominant
feature of established AAAs, evidence for the role of
inflammation in AAA rupture is lacking. Domanovits
et al.114 compared laboratory parameters of inflam-
mation (C-reactive protein [CRP] and white blood
count [WBC]) in 111 asymptomatic outpatients, 52
symptomatic patients without rupture and 62 patients
with aneurysm rupture. These authors reported that
patients with symptomatic and ruptured AAA had
significantly elevated serum CRP and WBC levels
compared to asymptomatic patients. As aneurysmal
pain was associated with elevated CRP and WBC,
Domanovits et al. proposed that an inflammatory
process is present in the aortic wall that promoted
rupture. However, their study failed to distinguish
whether the elevations in serum markers of inflam-
mation were due to a local vascular inflammatory
process or due to acute phase reaction accompanying
the systemic inflammatory response syndrome.
The functional importance of the immune response
in AAAs is not fully understood. The immune
response in AAAs may be primarily destructive,
encouraging connective tissue break down and vas-
cular smooth muscle cells apoptosis. On the other
hand, anti-inflammatory cytokines, such as interleu-
kin-4 (IL-4) and interleukin-10 (IL-10), can inhibit
macrophage activation and expression of MMPs and
may represent endogeneous mechanisms that counter
aneurysmal degeneration.105 These cytokines are
produced by CD4C T-cells within aneurysms115,116
and have been demonstrated to be elevated in human
AAAs.117,118
There is evidence linking immunosuppression to
AAA rupture but this is largely limited to anecdotal
accounts. Palm et al.119 reported rapid growth and
rupture of AAA in a patient who received chemother-
apy with gemcitabine, cisplatinum, prednisolone, and
dexamethasone for metastatic pancreatic carcinoma.
Fastest aneurysm growth coincided with chemother-
apy administration and when chemotherapy was notgiven for 3 months, there was no aneurysm growth
observed. Piotrowski et al.120 reported an increased
aneurysm growth rate and rupture at 4 cm diameter in
a cardiac transplant patient who was on a cyclospor-
ine, steroid and azathioprine immunosuppressive
regimen. The mechanism for the disadvantageous
effects of chemotherapy on AAA is unknown. At
present, the literature on the effect of chemotherapy on
the extracellular matrix is sparse. Furthermore, these
reports were unable to distinguish if aneurysm
rupture may be related to other effects of chemother-
apy, such as increased arterial pressure induced by
cyclosporine therapy, or due to the immunosuppres-
sive effects of chemotherapy per se. Reilly et al.121
showed that steroids induced aortic aneurysm rupture
in 90% of heterozygous female blotchy mice within 2
weeks and that this response was dose dependent. On
the contrary, Dobrin et al.122 showed that treatment
with corticosteroids effectively suppressed aneurys-
mal dilatation and reduced aortic wall elastin
degradation.Role of Intraluminal Thrombus in AAA
Rupture
Intraluminal thrombus (ILT) is found in about 75% of
all AAAs.123 Some authors have suggested that
rupture is associated with growth of thrombus in the
aneurysm.124 Acute haemorrhage seen in the mural
thrombus of patients with ruptured AAAs has led
others to suggest that blood entering thrombus may
have a role in rupture.125 Vorp et al.126 showed that
aneurysms with ILT thickness equal or greater than
4 mm had lower pO2 compared with aneurysms with
ILT less than 4 mm thick, consistent with their earlier
observation that ILT attenuated oxygen flow from the
lumen to the aortic wall.127 Vorp et al.126 also reported
that AAAs with thick ILT had greater inflammation,
increased expression of ORP (hypoxia specific poly-
peptide) and lower tensile strength. They postulated
that ILT, by creating a hypoxic environment may lead
to a compensatory inflammatory response, an increase
in local proteolytic activity of the wall,128–130 local wall
weakening and subsequent rupture.
In addition, early studies have shown that hypoxia
induced macrophages to enhance their bioreactiv-
ity,131–135 with subsequent increase in elastase pro-
duction.136 Adolph et al.137 reported ILT to be an active
and complex biological entity, containing many
inflammatory cells, including macrophages and neu-
trophils. Fontaine et al.138 showed that ILT was a
possible site of proteolytic enzyme release and
activation, and hypothesised that mural thrombusEur J Vasc Endovasc Surg Vol 30, September 2005
E. Choke et al.238acted as a source of proteolytic enzymes by aggregat-
ing platelets and trapping circulating cells and
adsorbing plasma components. The observation by
Jean-Claude et al.139 that elevated levels of plasmin
were present in the inner layers of the AAAwall near
the interface with ILT, supported this phenomenon of
proteolytic enzymes leeching from ILT. A more recent
study by Fontaine et al.140 showed that leukocytes in
the luminal pole of thrombus released MMP-9 and
MMP-8.
Early experimental work suggested that the avail-
ability of oxygen affected both the quantity and quality
of ECM synthesis.141–148 Aortic endothelial cells
cultured in hypoxic conditions exhibited a decrease
in collagen synthesis,145 whereas hypoxic arterial
SMCs exhibited a decrease in both collagen syn-
thesis146,149 and tropoelastin mRNA expression and
synthesis.142 Fibroblasts exposed to hypoxic con-
ditions also produced less collagen.143,147 Further-
more, hypoxic cells synthesised abnormal collagen,
because oxygen is needed for the hydroxylation of
proline.143 Kazi et al.150 compared the morphology of
aneurysm wall covered with thrombus to segments
exposed to flowing blood and illustrated the following
features to be associated with thrombus: thinner
aneurysm wall, fragmentation and decreased number
of elastin fibres, decreased numbers of SMCs,
increased number of inflammatory cells, and increased
SMC apoptosis. The thinner thrombus-covered wall
with less structural integrity may therefore predispose
this wall segment to rupture.
On the contrary, other investigators have reported
that intraluminal thrombus exerted protective influ-
ences against aneurysm rupture. Kushihashi et al.151
observed from CT images that mural thrombus was
significantly thinner in ruptured than in non-ruptured
aneurysms (9 vs. 19 mm). In another series of CT
analysis, Pillari et al.152 noted that aneurysm expansion
was associated with a synchronous increase in the
volume of intraluminal thrombus in those aneurysms
measuring 5–7 cm. However, expansion of aneurysms
greater than 7 cm was not associated with increase in
thrombus volume. The lower thrombus to lumen ratio
associated with larger (O7 cm) aneurysms suggested
that the thrombus may reach a point of maximum
relative volume and thus maximum protection for the
aneurysm.
Some studies have reported that ILT significantly
lowered aneurysm wall stress.45 However, Schurink et
al.48 demonstrated that the thrombus within an aortic
aneurysm failed to reduce transmission of pressure to
the aneurysm wall. Thubrikar et al.47 described a
different mechanism by which thrombus reduced wall
stress. Similar to the observations by Schurink et al.,48Eur J Vasc Endovasc Surg Vol 30, September 2005Thubrikar et al.47 reported that thrombus readily
transmitted pressure to the vessel wall. In vivo
measurements of pressure through mural thrombus
revealed that the aneurysm wall was subjected to
almost all (91G10%) of the intraluminal pressure.
However, when these investigators measured in vitro
dilatation of aneurysms during pressurisation before
and after the thrombus was removed, they observed
that the presence of thrombus was responsible for an
overall marked reduction in the aneurysm dilation. It
was proposed that mural thrombus acted as a fibrous
network adherent to the aneurysm wall and since this
network also had to stretch with the aneurysm, the
dilation of the aneurysm under pressure was reduced
in the presence of thrombus. Although the thrombus
transmitted most of the luminal pressure to the
aneurysm wall, the reduction in dilation (strain) was
thought to be important in reducing the overall wall
stress.Future Work
Several opportunities exist to advance our under-
standing of the biological processes underlying AAA
rupture.Collagenases
Given that the final common pathway of clinical
progression of AAAs to rupture is likely to involve
proteolytic degradation of aortic collagen fibres,
research efforts should focus on collagenases. The
triple-helix domains of interstitial collagens confer
intrinsic stability and resistance to enzymatic break-
down. The biologic degradation of interstitial collagen
requires two types of extracellular proteinases; col-
lagenases that cleave the triple helix domains of intact
collagen fibres in a characteristic locus, resulting in a
mixture of 1/4- and 3/4-length degradation frag-
ments, and secondly, gelatinases that subsequently
cleave denatured or partially hydrolysed forms of
collagen to more soluble peptides.153 Both types of
collagen-degrading activity are attributed to enzymes
of the MMP family, of which MMP-1, -8 and -13
function as interstitial collagenases under physiologic
conditions.153
The proteolytic capacity of collagenases in ruptured
AAAs has not been well documented in experimental
or clinical studies. Investigations on the role of MMP-8
(collagenase-2) are not straightforward. MMP-8 is
produced by polymorphonuclear neutrophils
(PMNs), and is sequestered in storage granules to be
Abdominal Aortic Aneurysm Rupture 239released upon cellular activation.154,155 In addition,
chondrocytes, synovial fibroblasts and vascular endo-
thelium can also express MMP-8.156,157 Mao et al.158
reported an inconsistent expression of MMP-8 in AOD
(2 of 4) and AAA (1 of 4) tissues. They postulated that
this inconsistent pattern could be attributed to the fact
that MMP-8 is stored as preformed protein in granules
in PMNs and therefore MMP-8 mRNA may not
accurately reflect protein concentration.Angiogenesis
Previous histological studies have demonstrated that
AAAs were associated with angiogenesis (formation
of new blood vessels from pre-existing blood
vessels).159,160 The role of angiogenesis in aneurysm
disease however remains undefined. Thompson et
al.160 demonstrated that the extent of angiogenesis
correlated with the degree of inflammation in the
aortic wall. There is evidence that hypoxia may induce
inflammatory cells to aggregate and secrete angiogenic
factors resulting in neovascularisation.126 In addition
to permitting oxygen and nutrient supply to the
hypoxic regions, neovascularisation will also result
in further inflammatory cell migration to aneurysmal
tissue and subsequent secretion of proteolytic
enzymes, potentially leading to wall weakening and
aortic rupture. Kobayashi et al.161 have demonstrated
that vascular endothelial growth factor (VEGF)
expressing cells were strongly related to the degree
of neovascularisation in AAAs. VEGF possesses
several unique attributes that make it an attractive
target for AAA rupture research. Specifically, it
promotes mitogenesis of vascular endothelial cells
and vascular permeability, and it also modulates
production of a number of proteolytic enzymes
involved in the process of neo-vascularisation. As a
result, VEGF plays a pivotal role in the initiation and
maintenance of angiogenesis, and is crucial in the
activation of pathways causing enzymatic breakdown
of matrix protein.162–164Conclusions
Collective endeavours in basic science research in the
past two decades have led to an accelerated pace of
progress in the understanding of aneurysm disease as
a unique pathophysiological process. In contrast,
research into biological factors involved in AAA
rupture is still at an early stage. Nevertheless, recent
developments are encouraging and the progress made
is beginning to alter our concepts of AAA rupture.It can be expected that clinical management will
eventual shift to include new medical therapeutic
strategies that limit aneurysm growth. It is hoped that
new insights into the processes underlying aneurys-
mal rupture will lead to novel medical therapies. A
model incorporating how biochemical, cellular, hae-
modynamic and proteolytic influences can conspire to
cause AAA rupture will be essential to the develop-
ment of pharmacologic agents that will not only retard
aneurysm growth but will more importantly, directly
inhibit aneurysm rupture.References
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